New evidence for coronary revascularisation

Session comprising selected EuroPCR 2026 late-breaking trials submissions

Anchorperson: H. Krumholz
Spokesperson: R. Davies
SHOW MORE

Summary

This session highlights new evidence in coronary revascularisation, including the role of CT-derived virtual stenting for procedural optimization, left ventricular unloading during complex PCI, long-term outcomes of FFR-guided PCI versus medical therapy, Impella CP support in high-risk PCI, and comparative results of PCI versus CABG in diabetic patients with multivessel disease.

Presentations available when logged in:

  • CT-derived virtual stenting to optimise revascularisation: one-year follow-up of CT-COMPASS trial
  • A randomised evaluation of left ventricular unloading in complex percutaneous coronary intervention
  • Ten-year outcomes of FFR-guided PCI vs. medical therapy in stable coronary artery disease: reconstructed IPD meta-analysis
  • Left ventricular support with Impella CP in high-risk PCI: PROTECT-EU registry
  • PCI vs. CABG in diabetic patients with multivessel disease: results from the TUXEDO 2 study